The Council of Ministers has approved this Tuesday a reform of the pharmaceutical co-payment system to make it more proportional to income. The idea is to incorporate a cap on the contribution of patients earning less than 35,000 euros per year, who today have no monthly limit on the expense of medicines financed by Social Security. In fact, the reform – which must first go through Congress – introduces four new contribution brackets and progressive monthly caps to benefit middle and low incomes, while aiming to prevent the abandonment of treatments for economic reasons. The Ministry of Health calculates that the savings for families will be around 265 million euros, although for the moment there is no date for the implementation of the new model.